Furthermore, by using logistics analysis, we determined the correlation between CHST12 expression and clinicopathological characteristics (T stage, N stage, M stage, pathologic stage, primary therapy outcome, gender, age, histologic grade, anatomic neoplasm subdivision, alcohol history, history of diabetes, and family history of cancer). This evidence concerns the gene CHST12 and cancer.